Lung Cancer ScreeningNCT07227480
Advancing Lung Cancer Screening One Text at a Time
A study testing Text messaging program and Educational material in people with Lung Cancer Screening, run by University of Rochester at 1 site in United States.
Trial summary
The purpose of this study is to assess the feasibility, acceptability, and preliminary impact of text messaging to promote lung cancer screening. Read more about this study
- Who is it for?
- Ages 50 to 80 years
- Conditions the study is for
- Lung Cancer Screening
- What is being tested?
- Text messaging program and Educational material
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 40 participants
- Where
- 1 siteUnited States
- Study dates
- 17 Feb 2026to Aug 2026
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 50 to 80 years
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- 50 to 80 years old
- have not completed their annual screening for lung cancer
- have a 20 pack-year smoking history
- currently smoke or have quit within the past 15 years
- speak English and/or Spanish
- have a functioning cellphone number with unlimited text messaging capacity
- be willing to complete a baseline and a follow-up (at Month 3) survey
Who cannot join
- being up-to-date on their annual lung cancer screening
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
United States1 site, 1 recruiting
- Recruiting
University of Rochester Medical Center
Rochester, New York, 14642
Francisco Cartujano, MD, 585-353-0035, francisco_cartujano@urmc.rochester.edu
Francisco Cartujano, MD
About this study
The purpose of this study is to assess the feasibility, acceptability, and preliminary impact of text messaging to promote lung cancer screening.
Read the detailed description
We will conduct a two-arm pilot randomized controlled trial with 40 adults. Participants will be randomized in a 1:1 ratio to either UR Screened (a text messaging program designed to promote lung cancer screening) or a control group (a mailed educational material along with a flyer for the lung cancer screening program). We will assess recruitment and follow-up rates, satisfaction with the program or educational material, and uptake of lung cancer screening at week 12. Additionally, we will compare screening rates between the intervention and control groups.
- Conditions
- Lung Cancer Screening
- Being tested
- Text messaging program, Educational material
- Keywords
- Lung Cancer Screening
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Text messaging programBehavioural
A text messaging program designed to promote lung cancer screening
Educational materialBehavioural
A mailed educational material along with a flyer for the lung cancer screening program
| Study group | Role | What they receive |
|---|---|---|
| UR Screened | Experimental | A text messaging program designed to promote lung cancer screening Receives: Behavioral: Text messaging program |
| Control group | Active comparator | A mailed educational material along with a flyer for the lung cancer screening program Receives: Behavioral: Educational material |
What is being measured
The primary outcome is the main question the study is designed to answer.
Percent of Participants Who Undergo Lung Cancer Screening
The proportion of study participants who complete a lung cancer screening test within 3 months of study enrollment
Measured: Month 3
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted12 Nov 2025
- Study start17 Feb 2026
- Primary completionAug 2026 (estimated)
- Study completionAug 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Lung Cancer ScreeningStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Screening
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Double blind
- Who is masked
- Investigator, Outcomes assessor
- Enrolment
- 40 participants (estimated)
Sponsor and investigators
- Lead sponsor
- University of Rochester
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Francisco Cartujano, MD, University of Rochester
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07227480
- Sponsor's protocol ID
- STUDY00010975
- Status last verified
- Feb 2026
- First submitted
- 10 Nov 2025
- Last updated
- 19 Feb 2026
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 19 Feb 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Advancing Lung Cancer Screening One Text at a Time
- ClinicalTrials.gov ID
- NCT07227480
- Acronym / sponsor ID
- STUDY00010975
- Conditions
- Lung Cancer Screening
- Keywords
- Lung Cancer Screening
- Study type
- Interventional
- Recruitment status
- Recruiting
- Enrolment
- 40 participants (estimated)
- Lead sponsor
- University of RochesterUniversity, hospital or other
- Study start
- 17 Feb 2026 (actual)
- Primary completion
- Aug 2026 (estimated)
- Study completion
- Aug 2026 (estimated)
- First posted
- 12 Nov 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The purpose of this study is to assess the feasibility, acceptability, and preliminary impact of text messaging to promote lung cancer screening.
Detailed description
We will conduct a two-arm pilot randomized controlled trial with 40 adults. Participants will be randomized in a 1:1 ratio to either UR Screened (a text messaging program designed to promote lung cancer screening) or a control group (a mailed educational material along with a flyer for the lung cancer screening program). We will assess recruitment and follow-up rates, satisfaction with the program or educational material, and uptake of lung cancer screening at week 12. Additionally, we will compare screening rates between the intervention and control groups.
Study design
- Primary purpose
- Screening
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Double blind (investigator, outcomes assessor)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| UR Screened | Experimental | Behavioral: Text messaging programA text messaging program designed to promote lung cancer screening |
| Control group | Active comparator | Behavioral: Educational materialA mailed educational material along with a flyer for the lung cancer screening program |
Who may qualify
- Ages
- 50 to 80 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (7 listed)
- 50 to 80 years old
- have not completed their annual screening for lung cancer
- have a 20 pack-year smoking history
- currently smoke or have quit within the past 15 years
- speak English and/or Spanish
Key exclusion criteria (1 listed)
- being up-to-date on their annual lung cancer screening
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Text messaging programA text messaging program designed to promote lung cancer screening | Behavioural | UR Screened |
| Educational materialA mailed educational material along with a flyer for the lung cancer screening program | Behavioural | Control group |
Primary outcome
Percent of Participants Who Undergo Lung Cancer Screening
Time frame: Month 3
The proportion of study participants who complete a lung cancer screening test within 3 months of study enrollment
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 19 Feb 2026.
Related trials for Lung Cancer Screening
Recruiting
A Restorative Justice-Based Lung Cancer Screening Decision-Making Support Intervention Tailored for Black Individuals to Increase Lung Cancer Screening Among Black Community Members, RESTORE Trial
Lung Carcinoma
Enrolling by invitationObservational study
Screening for Hematology Branch Protocols
Hematologic Disease and Disorders, Donors
Not yet recruitingObservational study
Clinical Genetics Branch Eligibility Screening Survey
Melanoma, Li-Fraumeni Syndrome
Active, not recruitingEarly Phase 1
Smoking Cessation Intervention During Low Dose CT (LDCT) Screening for Lung Cancer
Smoking Cessation
RecruitingObservational study
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Text messaging program and Educational material in people with Lung Cancer Screening, run by University of Rochester at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 7 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 19 Feb 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Francisco Cartujano, MD ((585) 273-1646, francisco_cartujano@urmc.rochester.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Percent of Participants Who Undergo Lung Cancer Screening (time frame: Month 3). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 Feb 2026.